NeueHealth Inc (NYSE:NEUE)
$ 6.75 (0%) Market Cap: 60.94 Mil Enterprise Value: 1.10 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 20/100

Q2 2025 NeueHealth Inc Earnings Call Transcript

Aug 07, 2025 / 12:00PM GMT
Release Date Price: $6.73 (-1.54%)

Key Points

Positve
  • NeueHealth Inc (NEUE) achieved adjusted EBITDA profitability for the sixth consecutive quarter, with $19 million in the second quarter.
  • The company reported a 45% increase in the number of consumers served compared to the same quarter last year, reflecting strong consumer satisfaction.
  • NeueHealth Inc (NEUE) is expanding its consumer-centric care model, which aligns with the industry's shift towards value-based care.
  • The company is collaborating with Walgreens to expand access to care by operating clinics inside select Walgreens locations.
  • NeueHealth Inc (NEUE) is advancing its data and analytics capabilities with the development of NeuePulse, an end-to-end value-based care enablement platform.
Negative
  • Consolidated revenue for the second quarter was $209.1 million, slightly lower than the prior year due to a shift in membership mix.
  • The company is facing uncertainties related to market trends impacting specific product areas.
  • There are risks and uncertainties associated with forward-looking statements that could affect future performance.
  • The transition to going private, led by an affiliate of NEA, is pending and subject to necessary closing conditions.
  • The company has a significant amount of restricted cash and investments, which may limit financial flexibility.
Operator

Good morning. Thank you for attending today's conference call. My name is Jerry, and I will be your moderator today. (Operator Instructions) I would now like to pass the conference over to our host, Emily Lombardi.

Emily Lombardi
NeueHealth Inc - AVP, Enterprise Strategy, Marketing and Communications at NeueHealth

Good morning, and welcome to NeueHealth's second-quarter 2025 earnings conference call. As a reminder, this call is being recorded. Leading the call today are NeueHealth's President and CEO; Mike Mikan and CFO, Jay Matushak. Before we begin, we want to remind you that this call may contain forward-looking statements under US federal securities laws.

These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission including the risk factors in our current and periodic reports we file with the SEC.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot